The launch of Mounjaro always raised the risk that it would cannibalise sales of Lilly's own GLP-1 agonist Trulicity (dulaglutide), which is competing head-to-head with Ozempic in the market ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in ... weekly injectable Trulicity taking on ...

Dr Noluthando Nematswerani, chief clinical officer at Discovery Health, said that the GLP-1 agonists (Ozempic, Trulicity, Victoza, Mounjaro, Soliqua) registered by SAHPRA for the treatment of type ...

A KKF poll finds that, overall, 12% of Americans have used or are using a GLP-1 agonist like Trulicity, Ozempic or Mounjaro for weight loss or to manage Type 2 diabetes and associated complications.

Higher volumes of drugs like Mounjaro, Zepbound, Verzenio, Jardiance and Taltz were partially offset by lower sales of Trulicity. Lilly’s new products also contributed to sales growth.

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

Shamoon has joined the wave of people who are taking limited amounts not of psychedelics — to which the microdosing trend usually applies — but of the diabetes drug Ozempic (semaglutide), and ...